TargED receives NWO Take-Off 2
Congratulations to the team of our portfolio company TargED Biopharmaceuticals, as they have been awarded a Take-Off 2 grant from NWO (the Dutch National Science Organization)!
NEWS
SentryX closes €3.2M seed funding round for the development of next generation pain relief therapeutics10/06/2021 - 09:54
TargED Biopharmaceuticals appoints Ludo Haazen, M.D. as Chief Medical Officer03/06/2021 - 16:46- NTrans Technologies closes Series A investment to accelerate development of gene editing therapy28/05/2021 - 10:28
